NL-OMON49082已完成不适用
Actigraphy as a new objective measure for apathy in schizophrenia - Actigraphy and Apathy
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 76
研究概览
简要总结
Trial is onging in other countries
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •- At least 18 y.o.a.
- •- Diagnosis schizophrenia
- •- Maximum score AES (27)
- •- Stable medication use (at least 4 weeks prior to inclusion)
- •- Written informed consent
- •- Participants should have a normal level of exercise tolerance and no physical
- •handicaps that limit their radius of action
- •- Participants should have weekends, wherein they are free from work (i.e. do
- •not have to work weekend shifts), Healthy subjects:
- •- At least 18 y.o.a.
- •- Maximum score AES (27)
- •- Written informed consent
- •- Participants should have a normal level of exercise tolerance and no physical
- •handicaps that limit their radius of action
- •- Participants should have weekends, wherein they are free from work (i.e. do
- •not have to work weekend shifts)
排除标准
- •- An apathy score above 27 on the apathy subscale of the AES-C
- •- Current disorder of substance abuse (excluding nicotine addiction)
- •- Insufficient Dutch language abilities, Healthy subjects:
- •- History of or current psychiatric or neurological illness
- •- An apathy score above 27 on the apathy subscale of the AES-S
- •- Insufficient Dutch language abilities
研究者
相似试验
已完成
不适用
Continuous measurements of vital signs, activity variables and exposure to air pollution in patients with COPDNL-OMON46270Vlaamse Instelling voor Technologisch Onderzoek29
已完成
4 期
An Open-Label Study of the Safety and Efficacy of ReFacto AF in Previously Untreated Patients in Usual Care Settingsfactor VIII deficiency1006447710005330Hemophilia ANL-OMON39506Pfizer1
已完成
不适用
Assessment of the responsiveness of the Rasch-built, CIPN-specific questionnaire (CIPN-RODS) to clinical changes in patients undergoing neurotoxic chemotherapy.chemotherapy-induced polyneuropathy1002765610034606NL-OMON42804niversitair Medisch Centrum5
已完成
2 期
An uncontrolled, pilot-study assessing the efficacy of octreotide LAR to decrease transfusion requirements and endoscopy frequency in patients with Rendu-Osler-Weber and gastrointestinal bleedingRendu-Osler-Weber and Hereditary hemorrhagic telangiectasia10017959NL-OMON43279Maag-, darm- en leverziekten11
已完成
不适用
A prospective cohort study to improve the AccUracy of Referrals to the emerGency departmEnt of patieNts with chesT pain: to decrease the delay in acute coronary syndrome patients and rule out non-cardiac chest pain patients (URGENT)acute coronary syndromehartattack10082206NL-OMON45470Viecuri Medisch Centrum voor Noord-Limburg40
